<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Data</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Data</journal-id>
    <journal-title-group>
      <journal-title>Scientific Data</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2052-4463</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7200764</article-id>
    <article-id pub-id-type="publisher-id">477</article-id>
    <article-id pub-id-type="doi">10.1038/s41597-020-0477-8</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Comment</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1473-370X</contrib-id>
        <name>
          <surname>Ostaszewski</surname>
          <given-names>Marek</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7137-4171</contrib-id>
        <name>
          <surname>Mazein</surname>
          <given-names>Alexander</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5766-1702</contrib-id>
        <name>
          <surname>Gillespie</surname>
          <given-names>Marc E.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kuperstein</surname>
          <given-names>Inna</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9687-7426</contrib-id>
        <name>
          <surname>Niarakis</surname>
          <given-names>Anna</given-names>
        </name>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8479-0262</contrib-id>
        <name>
          <surname>Hermjakob</surname>
          <given-names>Henning</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pico</surname>
          <given-names>Alexander R.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7542-0286</contrib-id>
        <name>
          <surname>Willighagen</surname>
          <given-names>Egon L.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff8">8</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Evelo</surname>
          <given-names>Chris T.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff8">8</xref>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hasenauer</surname>
          <given-names>Jan</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
        <xref ref-type="aff" rid="Aff11">11</xref>
        <xref ref-type="aff" rid="Aff12">12</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Schreiber</surname>
          <given-names>Falk</given-names>
        </name>
        <xref ref-type="aff" rid="Aff13">13</xref>
        <xref ref-type="aff" rid="Aff14">14</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1240-5553</contrib-id>
        <name>
          <surname>Dräger</surname>
          <given-names>Andreas</given-names>
        </name>
        <xref ref-type="aff" rid="Aff15">15</xref>
        <xref ref-type="aff" rid="Aff16">16</xref>
        <xref ref-type="aff" rid="Aff17">17</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Demir</surname>
          <given-names>Emek</given-names>
        </name>
        <xref ref-type="aff" rid="Aff18">18</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wolkenhauer</surname>
          <given-names>Olaf</given-names>
        </name>
        <xref ref-type="aff" rid="Aff19">19</xref>
        <xref ref-type="aff" rid="Aff20">20</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Furlong</surname>
          <given-names>Laura I.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff21">21</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2724-2002</contrib-id>
        <name>
          <surname>Barillot</surname>
          <given-names>Emmanuel</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3318-120X</contrib-id>
        <name>
          <surname>Dopazo</surname>
          <given-names>Joaquin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff22">22</xref>
        <xref ref-type="aff" rid="Aff23">23</xref>
        <xref ref-type="aff" rid="Aff24">24</xref>
        <xref ref-type="aff" rid="Aff25">25</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6632-883X</contrib-id>
        <name>
          <surname>Orta-Resendiz</surname>
          <given-names>Aurelio</given-names>
        </name>
        <xref ref-type="aff" rid="Aff26">26</xref>
        <xref ref-type="aff" rid="Aff36">36</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8076-7217</contrib-id>
        <name>
          <surname>Messina</surname>
          <given-names>Francesco</given-names>
        </name>
        <xref ref-type="aff" rid="Aff27">27</xref>
        <xref ref-type="aff" rid="Aff28">28</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Valencia</surname>
          <given-names>Alfonso</given-names>
        </name>
        <xref ref-type="aff" rid="Aff29">29</xref>
        <xref ref-type="aff" rid="Aff30">30</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0605-239X</contrib-id>
        <name>
          <surname>Funahashi</surname>
          <given-names>Akira</given-names>
        </name>
        <xref ref-type="aff" rid="Aff31">31</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kitano</surname>
          <given-names>Hiroaki</given-names>
        </name>
        <xref ref-type="aff" rid="Aff32">32</xref>
        <xref ref-type="aff" rid="Aff33">33</xref>
        <xref ref-type="aff" rid="Aff34">34</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2226-7411</contrib-id>
        <name>
          <surname>Auffray</surname>
          <given-names>Charles</given-names>
        </name>
        <xref ref-type="aff" rid="Aff35">35</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Balling</surname>
          <given-names>Rudi</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8278-1618</contrib-id>
        <name>
          <surname>Schneider</surname>
          <given-names>Reinhard</given-names>
        </name>
        <address>
          <email>reinhard.schneider@uni.lu</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2295 9843</institution-id><institution-id institution-id-type="GRID">grid.16008.3f</institution-id><institution>Luxembourg Centre for Systems Biomedicine, </institution><institution>University of Luxembourg, </institution></institution-wrap>Belvaux, Luxembourg </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0626 690X</institution-id><institution-id institution-id-type="GRID">grid.419890.d</institution-id><institution>Ontario Institute for Cancer Research, </institution></institution-wrap>Toronto, Canada </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1954 7928</institution-id><institution-id institution-id-type="GRID">grid.264091.8</institution-id><institution>College of Pharmacy and Health Sciences, </institution><institution>St. John’s University, </institution></institution-wrap>Queens, NY USA </aff>
      <aff id="Aff4"><label>4</label>Institut Curie, PSL Research University, Mines Paris Tech, Inserm, Paris, France </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1792 471X</institution-id><institution-id institution-id-type="GRID">grid.434726.0</institution-id><institution>Department of Biology, </institution><institution>Univ. Évry, University of Paris-Saclay, Genopole, </institution></institution-wrap>91025 Évry, France </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9709 7726</institution-id><institution-id institution-id-type="GRID">grid.225360.0</institution-id><institution>European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), </institution></institution-wrap>Hinxton, UK </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0572 7110</institution-id><institution-id institution-id-type="GRID">grid.249878.8</institution-id><institution>Institute of Data Science and Biotechnology, </institution><institution>Gladstone Institutes, </institution></institution-wrap>San Francisco, United States </aff>
      <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id><institution-id institution-id-type="GRID">grid.5012.6</institution-id><institution>Department of Bioinformatics-BiGCaT, NUTRIM, </institution><institution>Maastricht University, </institution></institution-wrap>Maastricht, The Netherlands </aff>
      <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id><institution-id institution-id-type="GRID">grid.5012.6</institution-id><institution>Maastricht Centre for Systems Biology, </institution><institution>Maastricht University, </institution></institution-wrap>Maastricht, The Netherlands </aff>
      <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0483 2525</institution-id><institution-id institution-id-type="GRID">grid.4567.0</institution-id><institution>Helmholtz Zentrum München, Institute of Computational Biology, </institution></institution-wrap>Neuherberg, Germany </aff>
      <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000000123222966</institution-id><institution-id institution-id-type="GRID">grid.6936.a</institution-id><institution>Center for Mathematics, Technische Universität München, </institution></institution-wrap>Garching, Germany </aff>
      <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2240 3300</institution-id><institution-id institution-id-type="GRID">grid.10388.32</institution-id><institution>Faculty of Mathematics and Natural Sciences, </institution><institution>University of Bonn, </institution></institution-wrap>Bonn, Germany </aff>
      <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0658 7699</institution-id><institution-id institution-id-type="GRID">grid.9811.1</institution-id><institution>University of Konstanz, Department of Computer and Information Science, </institution></institution-wrap>Konstanz, Germany </aff>
      <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7857</institution-id><institution-id institution-id-type="GRID">grid.1002.3</institution-id><institution>Monash University, Faculty of Information Technology, </institution></institution-wrap>Melbourne, Australia </aff>
      <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2190 1447</institution-id><institution-id institution-id-type="GRID">grid.10392.39</institution-id><institution>Computational Systems Biology of Infection and Antimicrobial-Resistant Pathogens, Institute for Bioinformatics and Medical Informatics (IBMI), </institution><institution>University of Tübingen, </institution></institution-wrap>72076 Tübingen, Germany </aff>
      <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2190 1447</institution-id><institution-id institution-id-type="GRID">grid.10392.39</institution-id><institution>Department of Computer Science, </institution><institution>University of Tübingen, </institution></institution-wrap>72076 Tübingen, Germany </aff>
      <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.452463.2</institution-id><institution>German Center for Infection Research (DZIF), partner site, </institution></institution-wrap>Tübingen, Germany </aff>
      <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9758 5690</institution-id><institution-id institution-id-type="GRID">grid.5288.7</institution-id><institution>Department of Molecular and Medical Genetics, School of Medicine, </institution><institution>Oregon Health &amp; Science University, </institution></institution-wrap>Portland, USA </aff>
      <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121858338</institution-id><institution-id institution-id-type="GRID">grid.10493.3f</institution-id><institution>Department of Systems Biology &amp; Bioinformatics, </institution><institution>University of Rostock, </institution></institution-wrap>Rostock, Germany </aff>
      <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2214 904X</institution-id><institution-id institution-id-type="GRID">grid.11956.3a</institution-id><institution>Stellenbosch Institute of Advanced Study (STIAS), </institution><institution>Wallenberg Research Centre at Stellenbosch University, </institution></institution-wrap>7602 Stellenbosch, South Africa </aff>
      <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2172 2676</institution-id><institution-id institution-id-type="GRID">grid.5612.0</institution-id><institution>Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute, Department of Experimental and Health Sciences, </institution><institution>Pompeu Fabra University, </institution></institution-wrap>Barcelona, Spain </aff>
      <aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9542 1158</institution-id><institution-id institution-id-type="GRID">grid.411109.c</institution-id><institution>Clinical Bioinformatics Area, Fundación Progreso y Salud. Hosp. Virgen del Rocío, </institution></institution-wrap>Sevilla, Spain </aff>
      <aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9542 1158</institution-id><institution-id institution-id-type="GRID">grid.411109.c</institution-id><institution>Bioinformatics in Rare Diseases. Centro de Investigación Biomédica en Red de Enfermedades Raras, Fundación Progreso y Salud, Hosp. Virgen del Rocío, </institution></institution-wrap>Sevilla, Spain </aff>
      <aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9542 1158</institution-id><institution-id institution-id-type="GRID">grid.411109.c</institution-id><institution>INB-ELIXIR-es, FPS, Hospital Virgen del Rocío, </institution></institution-wrap>Sevilla, 42013 Spain </aff>
      <aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9542 1158</institution-id><institution-id institution-id-type="GRID">grid.411109.c</institution-id><institution>Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, </institution></institution-wrap>41013 Sevilla, Spain </aff>
      <aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2353 6535</institution-id><institution-id institution-id-type="GRID">grid.428999.7</institution-id><institution>HIV, Inflammation and Persistence Unit, Virology Department, </institution><institution>Institut Pasteur, </institution></institution-wrap>Paris, France </aff>
      <aff id="Aff27"><label>27</label>Dipartimento di Epidemiologia Ricerca Pre-Clinica e Diagnostica Avanzata, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S., Rome, Italy </aff>
      <aff id="Aff28"><label>28</label>COVID 19 INMI Network Medicine for IDs Study Group, National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S., Rome, Italy </aff>
      <aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0387 1602</institution-id><institution-id institution-id-type="GRID">grid.10097.3f</institution-id><institution>Barcelona Supercomputer Center (BSC), </institution></institution-wrap>Barcelona, Spain </aff>
      <aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9601 989X</institution-id><institution-id institution-id-type="GRID">grid.425902.8</institution-id><institution>Institucio Catalana de Recerca I Estudis Avançats (ICREA), </institution></institution-wrap>Barcelona, Spain </aff>
      <aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9959</institution-id><institution-id institution-id-type="GRID">grid.26091.3c</institution-id><institution>Department of Biosciences and Informatics, </institution><institution>Keio University, </institution></institution-wrap>Yokohama, Kanagawa Japan </aff>
      <aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="GRID">grid.452864.9</institution-id><institution>The Systems Biology Institute, </institution></institution-wrap>Shinagawa, Tokyo Japan </aff>
      <aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9805 2626</institution-id><institution-id institution-id-type="GRID">grid.250464.1</institution-id><institution>Okinawa Institute of Science and Technology Graduate University, </institution></institution-wrap>Kunigami, Okinawa Japan </aff>
      <aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1764 0071</institution-id><institution-id institution-id-type="GRID">grid.452725.3</institution-id><institution>Sony Computer Science Laboratories, Inc., </institution></institution-wrap>Tokyo, Japan </aff>
      <aff id="Aff35"><label>35</label>European Institute for Systems Biology and Medicine (EISBM), Vourles, France </aff>
      <aff id="Aff36"><label>36</label>Bio Sorbonne Paris Cité, Université de Paris, Paris, France </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>5</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>5</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>7</volume>
    <elocation-id>136</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>4</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>24</day>
        <month>4</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1" abstract-type="Standfirst">
      <p id="Par1">Researchers around the world join forces to reconstruct the molecular processes of the virus-host interactions aiming to combat the cause of the ongoing pandemic.</p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Gene regulatory networks</kwd>
      <kwd>Cellular signalling networks</kwd>
      <kwd>Biochemical reaction networks</kwd>
      <kwd>Computational models</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2020</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <p id="Par2">We announce the COVID-19 Disease Map (10.17881/covid19-disease-map), an effort to build a comprehensive, standardized knowledge repository of SARS-CoV-2 virus-host interaction mechanisms, guided by input from domain experts and based on published work. This knowledge, available in the vast body of existing literature<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup> and the fast-growing number of new SARS-CoV-2 publications, needs rigorous and efficient organization in both human and machine-readable formats.</p>
  <p id="Par3">This endeavour is an open collaboration between clinical researchers, life scientists, pathway curators, computational biologists and data scientists. Currently, 162 contributors from 25 countries around the world are participating in the project, including partners from Reactome<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>, WikiPathways<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, IMEx Consortium<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, Pathway Commons<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, DisGeNET<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, ELIXIR<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, and the Disease Maps Community<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. With this effort, we aim for long-term community-based development of high-quality models and knowledge bases, linked to data repositories.</p>
  <p id="Par4">The COVID-19 Disease Map will be a platform for visual exploration and computational analyses of molecular processes involved in SARS-CoV-2 entry, replication, and host-pathogen interactions, as well as immune response, host cell recovery and repair mechanisms. The map will support the research community and improve our understanding of this disease to facilitate the development of efficient diagnostics and therapies. Figure <xref rid="Fig1" ref-type="fig">1</xref> illustrates the initial scope and layout of the map and its life cycle.<fig id="Fig1"><label>Fig. 1</label><caption><p>The overview of the COVID-19 Disease Map project. The map focuses on SARS-CoV-2 replication cycle, its interactions with the host, reaction of the immune system and repair mechanisms. The curated and reviewed content will be continuously integrated and cross-linked with data and knowledge bases, to support visual and computational exploration, as well as disease modelling efforts. The acquired results will benefit the research community and provide feedback to refine the scope of curation activities.</p></caption><graphic xlink:href="41597_2020_477_Fig1_HTML" id="d29e832"/></fig></p>
  <p id="Par5">At the time this Comment went to press, the COVID-19 Disease Map contains pathways of (i) the virus replication cycle and its transcription mechanisms; (ii) SARS-CoV-2 impact on ACE2-regulated pulmonary blood pressure, apoptosis, Cul2-mediated ubiquitination, heme catabolism, Interferon 2 and PAMP signalling, and endoplasmic reticulum stress; (iii) SARS-CoV-2 proteins Nsp4, Nsp6, Nsp14 and Orf3a. Moreover, the map incorporates the COVID-19 collection of WikiPathway diagrams<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> and a pre-published genome-scale metabolic model of human alveolar macrophages with SARS-CoV-2<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. All these contributed open-access resources are referenced at <ext-link ext-link-type="uri" xlink:href="https://fairdomhub.org/projects/190#models">https://fairdomhub.org/projects/190#models</ext-link>.</p>
  <p id="Par6">By combining diagrammatic representation of COVID-19 mechanisms with underlying models, the map fulfils a dual role. First, it is a graphical, interactive representation of disease-relevant molecular mechanisms linking different knowledge bases. Second, it is a computational resource of reviewed content for graph-based analyses<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> and disease modelling<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Thus, it provides a platform for domain experts, such as clinicians, virologists, and immunologists, to collaborate with data scientists and computational biologists for a rigorous model building, accurate data interpretation and drug repositioning. It offers a shared mental map to understand gender, age, and other susceptibility features of the host, disease progression, defence mechanisms, and response to treatment. Finally, it can be used together with the maps of other human diseases to study comorbidities.</p>
  <p id="Par7">In the construction of the COVID-19 Disease Map, we rely on multiple tools for curation and review the contributed content in a distributed, on-the-fly manner. Most importantly, already at this early stage, we involve practising physicians and clinical researchers to improve the scope and quality of the map. Motivated by our curation experience and the number of participants contributing to the construction of the map, we propose and regularly revise common curation guidelines and follow commonly-accepted exchange standards. Moreover, given the multicellular and multiorgan nature of COVID-19 infection and the complexity of the underlying molecular mechanisms, we envisage the map as a hierarchical structure of interconnected functional modules. We anticipate that the structure of the map will evolve as new knowledge about the disease is revealed.</p>
  <p id="Par8">This distributed, multi-tool, multi-group approach is dictated by the urgency of the ongoing pandemic, by the high volume of new COVID-19-related publications, and by an impressive response from the research community. In this challenging situation, it is imperative that community-based approaches are used to develop high-quality models and data. To ensure a transparent view of the contributors and community resources, we rely on the support of FAIRDOMHub<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. All data and curation guidelines related to the COVID-19 Disease Map are available at <ext-link ext-link-type="uri" xlink:href="https://fairdomhub.org/projects/190">https://fairdomhub.org/projects/190</ext-link>.</p>
  <p id="Par9">We invite curators to join the project and contribute to building a solid foundation of COVID-19 molecular and cellular mechanisms using systems biology standards<sup><xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref></sup>. Moreover, we request support from domain experts to advise on the content and to review the map, improving its quality and applicability, as well as experts in modelling to accelerate the development of efficient diagnoses, treatments, and vaccines in response to the ongoing pandemic.</p>
</body>
<back>
  <fn-group>
    <fn>
      <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We would like to acknowledge the members of the COVID-19 Disease Map Community. Their support, contributions and engagement make this project possible. All the members of the COVID-19 Disease Map Community can be found at <ext-link ext-link-type="uri" xlink:href="https://fairdomhub.org/projects/190">https://fairdomhub.org/projects/190</ext-link>. We would also like to acknowledge the FAIRDOMHub project members, in particular Martin Golebiewski, Carole Goble, Stuart Owen and Xiaoming Hu, for their support for COVID-19 Disease Map project on the FAIRDOMHub platform (<ext-link ext-link-type="uri" xlink:href="https://fairdomhub.org/">https://fairdomhub.org/</ext-link>).</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>All the authors have written and revised the manuscript.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par10">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fung</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>DX</given-names>
          </name>
        </person-group>
        <article-title>Human Coronavirus: Host-Pathogen Interaction</article-title>
        <source>Annu. Rev. Microbiol.</source>
        <year>2019</year>
        <volume>73</volume>
        <fpage>529</fpage>
        <lpage>557</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev-micro-020518-115759</pub-id>
        <pub-id pub-id-type="pmid">31226023</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="data">
        <year>2020</year>
        <data-title>COVID-19 Open Research Dataset (CORD-19).</data-title>
        <source>Semantic Scholar</source>
        <pub-id pub-id-type="publisher-id" xlink:href="https://pages.semanticscholar.org/coronavirus-research">https://pages.semanticscholar.org/coronavirus-research</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jassal</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Reactome pathway knowledgebase</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <fpage>D498</fpage>
        <lpage>D503</lpage>
        <?supplied-pmid 31691815?>
        <pub-id pub-id-type="pmid">31691815</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Slenter</surname>
            <given-names>DN</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research</article-title>
        <source>Nucleic Acids Res</source>
        <year>2018</year>
        <volume>46</volume>
        <fpage>D661</fpage>
        <lpage>D667</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1064</pub-id>
        <pub-id pub-id-type="pmid">29136241</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Orchard</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Protein interaction data curation: the International Molecular Exchange (IMEx) consortium</article-title>
        <source>Nat. Methods</source>
        <year>2012</year>
        <volume>9</volume>
        <fpage>345</fpage>
        <lpage>350</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.1931</pub-id>
        <pub-id pub-id-type="pmid">22453911</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rodchenkov</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Pathway Commons 2019 Update: integration, analysis and exploration of pathway data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <fpage>D489</fpage>
        <lpage>D497</lpage>
        <?supplied-pmid 31647099?>
        <pub-id pub-id-type="pmid">31647099</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Piñero</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The DisGeNET knowledge platform for disease genomics: 2019 update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <fpage>D845</fpage>
        <lpage>D855</lpage>
        <?supplied-pmid 31680165?>
        <pub-id pub-id-type="pmid">31680165</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <mixed-citation publication-type="other">Drysdale, R. <italic>et al</italic>. The ELIXIR Core Data Resources: fundamental infrastructure for the life sciences. <italic>Bioinforma. Oxf. Engl</italic>., 10.1093/bioinformatics/btz959 (2020).</mixed-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mazein</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms</article-title>
        <source>NPJ Syst. Biol. Appl</source>
        <year>2018</year>
        <volume>4</volume>
        <fpage>21</fpage>
        <pub-id pub-id-type="doi">10.1038/s41540-018-0059-y</pub-id>
        <pub-id pub-id-type="pmid">29872544</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <mixed-citation publication-type="other">COVID-19 Pathway Collection. <italic>WikiPathways</italic><ext-link ext-link-type="uri" xlink:href="https://www.wikipathways.org/index.php/Portal:Disease/COVIDPathways">https://www.wikipathways.org/index.php/Portal:Disease/COVIDPathways</ext-link> (2020).</mixed-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <mixed-citation publication-type="other">Renz, A., Widerspick, L. &amp; Dräger, A. FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2 (Version 3). Preprint at 10.5281/ZENODO.3752641 (2020).</mixed-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <mixed-citation publication-type="other">Villaveces, J. M., Koti, P. &amp; Habermann, B. H. Tools for visualization and analysis of molecular networks, pathways, and -omics data. <italic>Adv. Appl. Bioinforma. Chem. AABC</italic> <bold>8</bold>, 11–22 (2015).</mixed-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <mixed-citation publication-type="other">Ostaszewski, M. <italic>et al</italic>. Community-driven roadmap for integrated disease maps. <italic>Brief. Bioinform</italic><bold>20</bold>, 659–670 (2019).</mixed-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">Wolstencroft, K. <italic>et al</italic>. FAIRDOMHub: a repository and collaboration environment for sharing systems biology research. <italic>Nucleic Acids Res</italic> <bold>45</bold>, D404–D407 (2017).</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Le Novère</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Systems Biology Graphical Notation.</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2009</year>
        <volume>27</volume>
        <fpage>735</fpage>
        <lpage>741</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.1558</pub-id>
        <pub-id pub-id-type="pmid">19668183</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <mixed-citation publication-type="other">Hucka, M. <italic>et al</italic>. The Systems Biology Markup Language (SBML): Language Specification for Level 3 Version 2 Core Release 2. <italic>J. Integr. Bioinforma.</italic> <bold>16</bold>,1–181 (2019).</mixed-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <mixed-citation publication-type="other">Demir, E. <italic>et al</italic>. The BioPAX community standard for pathway data sharing. <italic>Nat. Biotechnol.</italic> <bold>28</bold>, 935–942 (2010).</mixed-citation>
    </ref>
  </ref-list>
</back>
